<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="executive-summary">
 <title>Key Points</title>
 <p>
  <list list-type="bullet">
   <list-item>
    <p>COVID-19 convalescent plasma (CP) may be a safe and effective treatment option in SARS-CoV-2 infection refractory to remdesivir.</p>
   </list-item>
   <list-item>
    <p>Infants may benefit from CP despite developing immune systems and donor variability emphasizes the need for characterization prior to use.</p>
   </list-item>
  </list>
 </p>
</abstract>
